MC1R and erythropoietic protoporphyria: MT-7117, or dersimelagon, is a selective agonist of MC1R that has been found to have a much higher selectivity for MC1R than NDP-MSH (afamelanotide), a peptide effective in treating erythropoietic protoporphyria (EPP).